Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 498 - Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms (21,960)
10/2005
10/19/2005EP0983348B1 Polyketides and their synthesis and use
10/19/2005CN1685232A Novel fluorescent label compounds
10/19/2005CN1683374A Indole carbazole alkaloid and its preparing method and use
10/18/2005US6956034 Oxazin(ethyl)one compounds used as fungicides
10/13/2005WO2005095401A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
10/13/2005WO2005095384A1 Pyrazine derivatives and pharmaceutical use thereof as adenosine antagonists
10/13/2005WO2005094833A1 Novel n-substituted dihydrobenzothiepino, dihydrobenzoxepino and tetrahydro benzocyclohepta indoles as selective estrogen receptor modulators
10/13/2005US20050228179 Thionation of a carbonyl compound comprising a nitrile group, the presence of a decoy agent comprising a nitrile group
10/13/2005US20050228012 Crystalline clopidogrel naphthalenesulfonate or hydrate thereof, method for preparing same and pharmaceutical composition containing same
10/13/2005US20050228009 2-(4-benzo[b]thiophen-3-yl-3,6-dihydro-2H-pyridin-1-ylmethyl)-2,3-dihydro-7H -[1,4]dioxino[2,3-e]indole; serotonin reuptake and serotonin receptor inhibitor; antidepressant, anxiolytic agent; dysthymia, panic disorder, attention deficit disorder obsessive, obesity, drug abuse, sexual dysfunction
10/13/2005US20050228003 Mitotic kinesin inhibitors
10/13/2005US20050227971 Thioamide derivatives as progesterone receptor modulators
10/13/2005US20050227963 Antiinflammatory agents
10/13/2005US20050227955 Reduction of the benzoquinone moiety to form a hydroquinone, and salt formation, producing 17-ammonium hydroquinone ansamycin analogs with improved solubility and air stability; antiproliferative and anticarcinogenic agents
10/13/2005CA2562126A1 Pyrazine derivatives and pharmaceutical use thereof
10/13/2005CA2558019A1 Alpha-trifluoromethyl alcohols or amines as glucocorticoid mimetics
10/12/2005EP1583972A2 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
10/12/2005EP1583757A1 Novel substituted nitrogen-containing heterobicycles and use thereof as factor xa inhibitors
10/12/2005EP1583537A2 Piperidine compounds as antibacterials
10/12/2005EP1015459B9 Tetrazole-containing rapamycin analogs with shortened half-lives
10/12/2005CN1681822A Antidepressant arylpiperazine derivatives of heterocycle-fused benzodioxans
10/12/2005CN1681821A Antidepressivt virkende cykloalkylaminderivater AV heterocykle-kondenserte benzodioksaner
10/12/2005CN1681820A Antidepressant piperidine derivatives of heterocycle-fused benzodioxans
10/12/2005CN1681817A Biologically active compounds
10/12/2005CN1679583A Pharmaceutical composition comprising condensed indole compound
10/12/2005CN1679559A Cancer treatment
10/12/2005CN1222529C Water soluble rapamycin esters
10/12/2005CN1222528C Process for purification of salt of clavulanic acid
10/11/2005US6953791 Dipeptide derivatives
10/06/2005WO2005092864A1 Imidazole compounds for the treatment of neurodegenerative disorders
10/06/2005US20050222425 Process for making amide acetals
10/06/2005US20050222409 Preparation of levofloxacin and forms thereof
10/06/2005US20050222244 Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
10/06/2005US20050222176 Piperidinylamino-thieno[2,3-D] pyrimidine compounds
10/06/2005US20050222175 New piperidinylamino-thieno[2,3-D] pyrimidine compounds
10/06/2005US20050222159 2,3-dihydropyridazin-3-ones e.g. 3-amino-6-(1-isopropyl-6-oxo-1,6-dihydro-3-pyridazinyl)-5-phenyl-2-pyrazinecarboxamide; adenosine antagonists; depression, dementia, Parkinson's disease, anxiety, pain, hypertension, obesity, gout, bronchial asthma
10/06/2005US20050222143 Helix mimetics and composition and methods related thereto
10/06/2005US20050222139 Non-peptide gnrh antagonists
10/06/2005US20050222125 For therapy of depression, anxiety and body weight disorders
10/06/2005US20050220823 Ophthalmic composition comprising ascomycin
10/05/2005EP1581521A1 Fused heterocyclic derivatives as ppar modulators
10/05/2005EP1581518A2 Substituted 1-piperidin-4-yl-4-pyrrolidin-3-yl-piperazine derivatives and their use as neurokinin antagonists
10/05/2005EP1581491A1 Indole derivatives as ppar modulators
10/05/2005EP1373273B1 Process for preparing maytansinol
10/05/2005CN1678372A Heterocyclic aromatic compounds useful as growth hormone secretagogues
10/05/2005CN1678312A Use of CCI-779 as an antineoplastic agent
10/05/2005CN1678310A Medicament containing disorazoles and derivatives thereof for the treatment of benign and malignant tumoral diseases
10/04/2005US6951938 Aryl fused azapolycyclic compounds
10/04/2005US6951863 Pyridoarylphenly oxazolidinone antibacterials, and related compositions and methods
10/04/2005US6951850 Dipeptide derivatives
10/04/2005CA2245539C Condensed 2,3-benzodiazepine derivatives and their use as ampa-receptor inhibitors
09/2005
09/29/2005WO2005090357A1 Tricyclic benzopyran compound as anti-arrhythmic agents
09/29/2005WO2005090294A2 PROCESS OF MAKING α-AMINOOXYKETONE/α-AMINOOXYALDEHYDE AND α-HYDROXYKETONE/α-HYDROXYALDEHYDE COMPOUNDS AND A PROCESS OF MAKING REACTION PRODUCTS FROM CYCLIC α,ß-UNSATURATED KETONE SUBSTRATES AND NITROSO SUBSTRATES
09/29/2005WO2005089754A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/29/2005WO2005089118A2 Novel bicyclic compounds as modulators of androgen receptor function and method
09/29/2005WO2005070940A3 Rifamycin derivatives effective against drug-resistant microbes
09/29/2005WO2005054234A3 Substituted piperidino phenyloxazolidinones having antimicriobial activity with improved in vivo efficacy
09/29/2005WO2005025507A3 Dihydropyridine compounds for treating or preventing metabolic disorders
09/29/2005WO2005009398A3 Tetracyclic benzamide derivatives and methods of use thereof
09/29/2005US20050215610 Such as 3-(4-(2-[2-(3,5-Difluoro-phenyl)-acetylamino]-pentanoylamino)-imidazol-1-yl)-butyric acid methyl ester; secretase, A beta -peptide inhibitor; neurogenerative and neurological diseases: Alzheimer's disease; Notch signaling pathway inhibitor; antiinflammatory agent, asthma, autoimmune diseases
09/29/2005US20050215556 Macrocyclic kinase inhibitors
09/29/2005US20050215547 Optically active pyridine derivative and a medicament containing the same
09/29/2005CA2557054A1 (indol-3-yl)-heterocycle derivatives as agonists of the cannabinoid cb1 receptor
09/28/2005EP1580187A1 Apoptogenic and antiproliferative analogs of ceramide
09/28/2005EP1578752A1 Method for producing pyridoxine or an acid addition salt thereof
09/28/2005EP1578743A2 Antibacterial agents
09/28/2005EP1578705A2 Medical devices containing rapamycin analogs
09/28/2005EP1183260B1 Triphendioxazine compounds
09/28/2005CN1675225A Macrocyclic pyrimidines, their production and use as pharmaceutical agents
09/28/2005CN1675224A Fused heterocyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675223A C6- and C9-substituted isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675222A C-substituted tricyclic isoxazoline derivatives and their use as anti-depressants
09/28/2005CN1675187A Co-surfactants based on aldehydes
09/28/2005CN1673221A Isoxazoline derivative and herbicide comprising the same as active ingredient
09/27/2005US6949578 useful in selectively inhibiting or antagonizing the alpha v beta 3 and/or alpha v beta 5 integrins; treatment of osteoporosis, humoral hypercalcemia of malignancy, Paget's disease, tumor metastasis, solid tumor growth (neoplasia), angiogenesis
09/27/2005US6949562 Heterocyclic compounds as ligands of the GABAA receptor
09/22/2005WO2005087769A1 Fused ring azadecalin glucocorticoid receptor modulators
09/22/2005WO2005087232A1 Bicyclic modulators of androgen receptor function
09/22/2005US20050209276 Etherification, dehalogenation; filtration, crystallization; bactericides
09/22/2005US20050209266 nitrosated 42-deoxy-42-(1H-tetrazol-1-yl)-rapamycin; endothelium-derived relaxing factor (EDRF) agonist; anticoagulant and platelet inhibition agents; restenosis, atherosclerosis, thrombosis; stent coating; minimize interaction between blood and artificial surfaces; mix with nitric oxide donor compound
09/22/2005US20050209262 Process for producing optically active sulfoxide
09/22/2005US20050209225 Substituted indoles and their use as integrin antagonists
09/22/2005US20050209224 N4-(4H-5-pyrid[1,4]oxazin-6-yl)-2,4-pyrimidinediamine derivatives; for treating rheumatoid arthritis
09/22/2005US20050209210 Having activity against both rifampin and ciprofloxacin-resistant microorganisms
09/22/2005US20050209191 1-Aza-dibenzoazulenes as inhibitors of tumour necrosis factor production and intermediates for the preparation thereof
09/22/2005US20050208598 Biotin recognition sensors and high-throughput assays
09/22/2005CA2558899A1 Fused ring azadecalin glucocorticoid receptor modulators
09/21/2005EP1577301A1 Diamine derivatives
09/21/2005EP1575952A1 Synthesis of heteroaryl acetamides
09/21/2005EP1140091B1 Formulations comprising imiquimod or other immune response modifiers for treating cervical dysplasia
09/21/2005CN1671800A Fibre-reactive azo dyes, their preparation and their use
09/21/2005CN1671711A Calcitonin gene related peptide receptor antagonists
09/21/2005CN1671690A Antimicrobial aza-bicyclic derivates, their compositions and uses
09/20/2005US6946473 4-((4-But-2-ynyloxy-benzenesulfonyl)-methyl-amino)-1,3-dimethy l-1H- pyrazolo(3,4-b)and dericatives; bioavailability; no pharmacokinetic problems; bioselectiveity; rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis
09/15/2005WO2005085257A1 Macrolides and methods for producing same
09/15/2005WO2005051300A3 Bicyclic inhibitors of mek and methods of use thereof
09/15/2005WO2005049604A3 Antithrombotic aromatic ethers
09/15/2005US20050203296 Piperazine substituted aryl benzodiazepines and their use as dopamine receptor antagonists for the treatment of psychotic disorders
09/15/2005US20050203154 Novel tetracyclic arylsulfonyl indoles having serotonin receptor affinity useful as therapeutic agents, process for their preparation and pharmaceutical compositions containing them
09/15/2005US20050203122 Benzenesulfonic acid salts of clopidogrel, methods for preparing same, and pharmaceutical formulations thereof
1 ... 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 113 114 115 116 ... 220